Children with Down's syndrome are more likely to get leukaemia: stem-cells hint at why
Sep 25, 2024
auto_awesome
Discover how children with Down's syndrome face a 150-fold increased risk of leukaemia due to genetic factors linked to chromosome 21. Researchers investigate fetal liver stem cells and their role in DNA packaging, shedding light on leukaemia susceptibility. Meanwhile, learn about innovative studies showing that smaller beer servings can curtail alcohol intake, and meet Costa Rican lizards equipped with self-made air supplies for underwater survival. Plus, explore how tiny crustaceans use scent to navigate and the potential of nuclear techniques in asteroid deflection.
Children with Down syndrome face a significant 150-fold increased risk of leukemia due to genetic mutations during fetal liver stem-cell development.
Research indicates that structural changes in chromatin caused by an extra chromosome influence blood cell differentiation, heightening leukemia susceptibility.
Deep dives
Understanding leukemia risk in children with Down syndrome
Children with Down syndrome have a significantly heightened risk of developing leukemia, particularly in the first five years of life, with a 150-fold increase compared to their peers. This risk is believed to originate during fetal development, as genetic mutations and changes in blood cell production are observed early on. Research reveals that hematopoietic stem cells, which give rise to various blood cells, demonstrate altered behaviors influenced by the presence of an extra copy of chromosome 21. Overall, these insights emphasize the need for further investigation into the genetic and developmental pathways leading to this elevated leukemia risk.
Cellular changes linked to chromosome 21
Investigating the fetal liver of children with Down syndrome, researchers found an increase in the number of stem cells that predominantly differentiate into red blood cells and platelets. This shift is attributed to alterations in chromatin structure caused by the additional chromosome, impacting gene expression and cellular development. By analyzing the genome of these stem cells, it was revealed that the restructuring of chromatin accessibility narrows down their differentiation options, favoring the erythroid lineage over immune cells. This indicates a fundamental change in the regulatory mechanisms guiding blood cell formation in these individuals.
Oxidative stress and mutation susceptibility
The presence of an extra chromosome in Down syndrome results in oxidative stress within stem cells, potentially introducing mutations to their DNA. Reactive oxygen species produced during this stress can damage cellular components and disrupt genetic integrity, laying the groundwork for the development of leukemia. Additionally, the research uncovered that chromatin modifications create regions where mutations are more likely to occur, further contributing to the risk. Understanding these underlying mechanisms could aid in developing strategies to reduce the risk of leukemia and improve health outcomes for children with Down syndrome.
00:46 Unravelling why children with Down’s syndrome are at a higher risk of leukaemia
Children with Down’s syndrome have a 150-fold increased risk of developing leukaemia than those without the condition. Now, an in-depth investigation has revealed that changes to genome structures in fetal liver stem-cells appear to be playing a key role in this increase.
Down’s syndrome is characterised by cells having an extra copy of chromosome 21. The team behind this work saw that in liver stem-cells — one of the main places blood is produced in a growing fetus — this extra copy results in changes in how DNA is packaged in a nucleus, opening up areas that are prone to mutation, including those known to be important in leukaemia development.
The researchers hope their work will be an important step in understanding and reducing this risk in children with Down’s syndrome.